AstraZeneca Options Trading: A Deep Dive Into Market Sentiment
AstraZeneca Options Trading: A Deep Dive Into Market Sentiment
In terms of liquidity and interest, the mean open interest for AstraZeneca options trades today is 2727.71 with a total volume of 14,580.00.Financial giants have made a conspicuous bearish move on AstraZeneca. Our analysis of options history for AstraZeneca (NASDAQ:AZN) revealed 9 unusual trades.
金融巨頭對阿斯利康採取了明顯的看淡行動。我們對阿斯利康（NASDAQ：AZN）期權歷史的分析顯示，出現了9次異常交易。
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $353,099, and 5 were calls, valued at $822,380.
進一步了解細節，我們發現33%的交易者看漲，而66%的交易者表現出看淡的趨勢。在我們發現的所有交易中，有4次看跌交易，價值爲353,099美元，有5次看漲交易，價值爲822,380美元。
Projected Price Targets
預計價格目標
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $79.0 and $87.5 for AstraZeneca, spanning the last three months.
在評估交易量和持倉情況後，很明顯，主要的市場動力者正專注於阿斯利康的79.0美元至87.5美元之間的價格區間，涵蓋了過去三個月。
Volume & Open Interest Trends
成交量和未平倉量趨勢
In terms of liquidity and interest, the mean open interest for AstraZeneca options trades today is 2727.71 with a total volume of 14,580.00.
就流動性和利益而言，阿斯利康期權今日的平均持倉利益爲2727.71，總成交量爲14,580.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for AstraZeneca's big money trades within a strike price range of $79.0 to $87.5 over the last 30 days.
在下圖中，我們可以跟蹤阿斯利康大手交易的成交量和持倉利益的發展，這些交易的行權價格範圍爲79.0美元至87.5美元，跨過了過去30天。
AstraZeneca Option Activity Analysis: Last 30 Days
阿斯利康期權活動分析：最近30天
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | CALL | TRADE | BULLISH | 09/20/24 | $0.86 | $0.8 | $0.85 | $85.00 | $671.5K | 3.6K | 7.9K |
| AZN | PUT | TRADE | BULLISH | 10/11/24 | $0.81 | $0.57 | $0.61 | $79.00 | $250.1K | 0 | 4.1K |
| AZN | CALL | SWEEP | BEARISH | 01/17/25 | $4.3 | $4.25 | $4.25 | $85.00 | $42.5K | 1.3K | 132 |
| AZN | CALL | SWEEP | BULLISH | 01/17/25 | $4.25 | $4.2 | $4.25 | $85.00 | $42.4K | 1.3K | 232 |
| AZN | PUT | SWEEP | BEARISH | 09/20/24 | $2.16 | $2.13 | $2.16 | $85.00 | $41.6K | 5.3K | 634 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | 看漲 | 交易 | 看好 | 09/20/24 | 每股0.86美元 | $0.8 | $0.85 | $85.00 | $671.5K | 3.6千 | 7.9K |
| AZN | 看跌 | 交易 | 看好 | 10/11/24 | $0.81 | $0.57 | $0.61 | 79.00美元 | $250.1K | 0 | 4.1K |
| AZN | 看漲 | SWEEP | 看淡 | 01/17/25 | $4.3 | $4.25 | $4.25 | $85.00 | $42.5K | 1.3K | 132 |
| AZN | 看漲 | SWEEP | 看好 | 01/17/25 | $4.25 | $4.2 | $4.25 | $85.00 | $42.4K | 1.3K | 232 |
| AZN | 看跌 | SWEEP | 看淡 | 09/20/24 | $2.16 | $2.13 | $2.16 | $85.00 | $41.6千 | 5.3K | 634 |
About AstraZeneca
關於阿斯利康
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
1999年，瑞典的阿斯利和英國的Zeneca集團合併，形成了阿斯利康。該公司銷售多個主要治療領域的品牌藥物，包括胃腸道、糖尿病、心血管、呼吸系統、癌症、免疫學和罕見病。大部分銷售額來自國際市場，其中美國佔銷售額的近三分之一。
Following our analysis of the options activities associated with AstraZeneca, we pivot to a closer look at the company's own performance.
在對阿斯利康相關期權交易活動進行分析後，我們轉而更詳細地觀察該公司自身的表現。
Where Is AstraZeneca Standing Right Now?
阿斯利康現狀如何？
- With a volume of 4,170,981, the price of AZN is down -3.44% at $82.8.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 63 days.
- 阿斯利康的成交量爲4,170,981，股價下跌了-3.44%，爲$82.8。
- RSI指標暗示該標的股票目前處於超買和超賣的中立區間。
- 下一次業績預計在63天發佈。
What Analysts Are Saying About AstraZeneca
有關阿斯利康的分析師意見
In the last month, 1 experts released ratings on this stock with an average target price of $95.0.
在過去一個月中，有1位專家對這隻股票進行了評級，平均目標價爲95.0美元。
- An analyst from TD Cowen persists with their Buy rating on AstraZeneca, maintaining a target price of $95.
- TD Cowen的分析師堅持將阿斯利康評級爲買入，並保持目標價95美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AstraZeneca with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易員通過持續的教育、戰略性的交易調整、利用各種因子以及對市場動態的敏感來降低這些風險。通過Benzinga Pro實時提醒，了解阿斯利康的最新期權交易。
譯文內容由第三人軟體翻譯。
